Inactivation of pathogens in blood and blood products
Ben-Hur, E.
Medicine and Health Rhode Island 81(12): 396-399
1998
ISSN/ISBN: 1086-5462 PMID: 9884539 Document Number: 484291
Document emailed within 1 workday
Related Documents
Ruebsaamen, M. 1995: Liability for HIV infection by blood and blood products: A summary of the most important results of the final report of the 3rd fact-finding committee HIV infections by blood and blood products of the 12th German Bundestag AIDS-Forschung 10(6): 305-318Horowitz, B. 1991: Specific inactivation of viruses which can potentially contaminate blood products Developments in Biological Standardization 75: 43-52
Blajchman, M.A.; Shepherd, F.A.; Perrault, R.A. 1979: Clinical use of blood, blood components and blood products Canadian Medical Association Journal 121(1): 33-42
Dressel, H. 1989: The effects and properties of sodium nucleinate as a pyrogen working standard. 6. Pyrogen inactivation by incubation with blood serum or blood plasma Die Pharmazie 44(12): 840-842
Noizat-Pirenne, F.; Wautier, J.-L. 2008: Blood transfusion and blood-derived products: prescription, complications. Risk management La Revue du Praticien 58(6): 679-685; Quiz 685
Escott, M.E.A.; Bank, E.A.; Mehkri, F.M.; Monroe, B.J. 2017: Blood Therapy: Considerations for using blood products for prehospital trauma patients Jems: a Journal of Emergency Medical Services 42(3): 47-51; 67
Ten Duis, H.J.; van Dalen, K.C.; Giovanetti, A.M.; Smit Sibinga, C.T.; Sirchia, G. 1996: The use of blood and blood products in total hip arthroplasty in 31 European hospitals, 1990/'91 Nederlands Tijdschrift Voor Geneeskunde 140(25): 1307-1312
Perdue, S.T.; Terasaki, P.I. 1983: Effects of blood transfusions on renal transplants: considering exclusive blood products and donor relationship Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 20: 253-262
Franceschi, S.; Dal Maso, L.; La Vecchia, C. 1995: Trends in incidence of AIDS associated with transfusion of blood and blood products in Europe and the United States, 1985-93 BMJ 311(7019): 1534-1536
Wautier, J.L. 1991: Blood transfusion and products derived from blood (except platelets and leukocyte concentrates). Immunologic bases and indications La Revue du Praticien 41(23): 2354-2356
Trouvin, J.-H. 2005: Viral safety concept: application to blood and blood products La Revue du Praticien 55(18): 2033-2038
Sepúlveda Amor, J.; de Lourdes García, M.; Domínguez Tórix, J.L.; Valdespino Gómez, J.L. 1989: Prevention of HIV transmission through blood and blood products: experiences in Mexico Bulletin of the Pan American Health Organization 23(1-2): 108-114
Tohyama, H. 1986: Recent circumstances in the supply and demand of various blood products in Japan, and appropriate use of blood components or plasma protein derivatives Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(11): 3095-3104
Shenkman, Z.; Hoffman, B.; Glantz, L.; Yehezkel, D. 1992: Perioperative blood and blood products--indications and contraindications Harefuah 122(10): 661-664
Robertson, B.H.; Erdman, D.D. 2000: Non-enveloped viruses transmitted by blood and blood products Developments in Biologicals 102: 29-35
Yap, P.L. 1997: Viral transmission by blood products: a perspective of events covered by the recent tribunal of enquiry into the Irish Blood Transfusion Board Irish Medical Journal 90(3): 84 86 88
Hitzler, W.E.; Runkel, S. 2001: Screening of Blood Donations by Hepatitis C Virus Polymerase Chain Reaction (HCV-PCR) Improves Safety of Blood Products by Window Period Reduction Clinical Laboratory 47(5-6): 219-222
Seifried, E.; Soedel, G. 1995: Costs of safety of blood and blood products Zentralblatt für Chirurgie 120(8): 584-592
Dodsworth, H. 1995: Making sense of the use of blood and blood products Nursing Times 91(1): 25-27
Algora Weber, M.; Fernández Montoya, A.; Gómez Villagrán, J.L.; Martín Vega, C.; Prats Arrojo, I.; Puig Alcaraz, N.; Pujol Bosch, M.; Vesga Carasa, M.A. 1999: Guide for transfusion of red blood cells, platelets and labile plasma products. Joint directive of the Spanish society of blood transfusion Medicina Clinica 113(12): 471-474